Related Experiment Video
Updated: Mar 19, 2026
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
11.0K
Analysing adverse events by time-to-event models: the CLEOPATRA study
Tanja Proctor1,2, Martin Schumacher1
1Institute for Medical Biometry and Statistics, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany.
Pharmaceutical Statistics
|June 18, 2016
Summary
Time-to-event models offer a more comprehensive analysis of serious adverse events in clinical trials than traditional frequency tables. These statistical methods, applied to the CLEOPATRA study, reveal crucial temporal dynamics often missed in standard reporting.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Oncology
Background:
- Clinical trials commonly use time-to-event models for primary endpoints like survival.
- Adverse event analysis often relies on simple frequency tables, neglecting treatment duration differences.
- The CLEOPATRA study compared treatment regimens for HER2-positive metastatic breast cancer.
Purpose of the Study:
- To demonstrate the application of time-to-event models for analyzing serious adverse events (SAEs) in clinical trials.
- To compare various time-to-event models, including survival, competing risks, and multi-state models, for SAE analysis.
- To highlight the added value of time-to-event models over traditional frequency tables for understanding SAEs.
Main Methods:
- Applied time-to-event models (incidence rate, survival, competing risks, multi-state) to SAE data from the CLEOPATRA study.
- Utilized graphical displays to illustrate temporal dynamics of SAEs.
- Compared results obtained from different time-to-event models.
Main Results:
- Time-to-event models provide valuable insights into the temporal dynamics of serious adverse events.
- Results from different time-to-event models for the CLEOPATRA study showed hazard ratios of similar magnitude.
- Standard frequency tables may overlook critical information regarding the timing of adverse events.
Conclusions:
- Time-to-event models are essential for a thorough analysis of serious adverse events in clinical trials, especially when treatment durations vary.
- These models adequately capture the temporal relationship between adverse events and patient death.
- Adopting time-to-event models enhances the understanding of patient safety in oncology trials.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
692
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
692
01:18Introduction To Survival Analysis
924
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
924
01:21Cancer Survival Analysis
812
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812
01:15Assumptions of Survival Analysis
478
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
478
01:09Censoring Survival Data
629
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
629
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520